Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. There are no observable changes to study details or core content.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the older notices, including the lapse in government funding message and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T11:37:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice warning of possible delays in updating information and directing users to cc.nih.gov and opm.gov for status. Updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata refinements were added (glossary toggle, updated last update labels, and version information), while the core study data and eligibility details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T05:57:33.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; there are no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:48:41.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section added listing Texas sites (Conroe, The Woodlands, Houston, and West Houston MD Anderson campuses); HHS Vulnerability Disclosure and Texas Locations were removed, and the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:22:52.000Z thumbnail image

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.